+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Nivolumab Market Report 2025 - Product Thumbnail Image

Nivolumab Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
From
Injectable Hematology Growth Factors Report - Product Thumbnail Image

Injectable Hematology Growth Factors Report

  • Report
  • January 2024
  • Global
From
From
Glioma Treatment Market Report 2025 - Product Thumbnail Image

Glioma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nasal Polyposis Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasal Polyposis Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 382 Pages
  • Global
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • October 2025
  • 93 Pages
  • Global
From
From
From
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
Loading Indicator